A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)
Part of paid clinical trials in Tempe, Arizona.
- Sponsor
- Merck Sharp & Dohme LLC
- Study ID
- NCT07044479
- Phase
- PHASE1
- Status
- Completed
Conditions
- Healthy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Accepted
Interventions
- Enlicitide — DRUGSingle dose of enlicitide is administered orally on day 1 of each testing period
Study Details
The goal of this study is to learn what happens to enlicitide in a person's body over time when enlicitide is taken at the same time as coffee or tea. Researchers will measure the amount of enlicitide in the blood when taken with coffee or tea compared with enlicitide taken with water.
Key Dates
- Start date
- Jul 3, 2025
- Status verified
- Aug 2025
- Primary completion
- Aug 13, 2025
- Completion
- Aug 28, 2025
Study Design
- Enrollment
- 60 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Enlicitide Coffee Sequence 1Participants will be randomized to receive enlicitide administered with water in period 1 and enlicitide with coffee in period 2.
- Experimental: Enlicitide Coffee Sequence 2Participants will be randomized to receive enlicitide administered with coffee in period 1 and enlicitide with water in period 2.
- Experimental: Enlicitide Tea Sequence 1Participants will be randomized to receive enlicitide administered with water in period 1 and enlicitide with tea in period 2.
- Experimental: Enlicitide Tea Sequence 2Participants will be randomized to receive enlicitide administered with tea in period 1 and enlicitide with water in period 2.
Primary Outcome Measure
Part 1-Coffee: Area Under the Concentration-Time Curve from Time 0 to Infinity (AUC0-Inf) of Enlicitide [ Time Frame: Predose and at designated time points up to 168 hours ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Celerion, Inc. ( Site 0001) | Tempe | Arizona | 85283 | - |
Find similar trials in Tempe, AZ
By research site
Related Studies
- A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut DysbiosisRecruiting · Mayo Clinic · Scottsdale, Arizona
- A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's DiseaseRecruiting · Mayo Clinic · Scottsdale, Arizona
- Bone Mineral Density Agreement Study Between EOSedge™ Versus Traditional DXARecruiting · Alphatec Spine, Inc. · Phoenix, Arizona
- Increasing Physical Activity Through Social Support and Stress ResilienceRecruiting · Arizona State University · Phoenix, Arizona